[3H]DOPA formed from [3H]tyrosine in living rat brain is not committed to dopamine synthesis

Journal of Cerebral Blood Flow and Metabolism

Volumn 18, Issue 5, 1998, Pages 491-499

  Cumming, Paul ^a   Ase, Ariel ^b   Kuwabara, Hiroto ^c   Gjedde, Albert ^a,d  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c WEST VIRGINIA UNIVERSITY   (United States)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

DOPA; DOPA decarboxylase; Dopamine; Haloperidol; Metabolism; NSD 1015; Protein synthesis; Striatum; Tyrosine; Tyrosine hydroxylase

Indexed keywords

3 HYDROXYBENZYLHYDRAZINE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPA; DOPA DECARBOXYLASE INHIBITOR; DOPAMINE; HALOPERIDOL; TYROSINE; TYROSINE 3 MONOOXYGENASE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; CORPUS STRIATUM; DECARBOXYLATION; DOPAMINE METABOLISM; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; ANIMAL; BIOSYNTHESIS; BRAIN; BRAIN CIRCULATION; METABOLISM; VASCULARIZATION; WISTAR RAT;

ANIMALS; BRAIN; CEREBROVASCULAR CIRCULATION; DIHYDROXYPHENYLALANINE; DOPAMINE; MALE; RATS; RATS, WISTAR; TRITIUM; TYROSINE; TYROSINE 3-MONOOXYGENASE;

EID: 0031596987     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-199805000-00004     Document Type: Article

References (36)

1. Argiolas A, Melis MR, Fadda F, Serra G, Gessa GL (1982) Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra. J Neurochem 38:75-79
2. Carlsson A, Davis JN, Kehr W, Lundqvist M, Atack CV (1972) Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn Schmiedebergs Arch Pharmacol 275: 153-168
3. Coenen HH, Kling P, Stöcklin G (1989) Cerebral metabolism of L-[2-18F]fluorotyrosine, a new PET tracer of protein synthesis. J Nucl Med 30:1367-1372
4. Cumming P, Ase A, Laliberté C. Kuwabara H, Gjedde A (1997) In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain. J Cereb Blood Flow Metab 17:1254-1260
5. 18F]fluoro-L-dihydroxyphenylalanine (FDOPA) metabolism in the rat. J Neurochem 63:1675-1682
6. Cumming P, Kuwabara H, Ase A, Gjedde A (1995) Regulation of DOPA-decarboxylase activity in brain of living rats. J Neurochem 65:1381-1390
7. 14C]methyl-pora-tyrosine in the rat. Synapse 17:125-128
8. During MJ, Acworth IN, Wurtman RJ (1988) Effects of systemic L-tyrosine on dopamine release from rat corpus striatum and nucleus accumbens. Brain Res 452:378-380
9. Eisenhofer G, Brush JE, Cannon RO III, Stull R, Kopin IJ, Goldstein S (1989) Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans. J Clin Endocrinol Metab 68:247-255
10. Eldrup E, Hetland ML, Christensen NJ (1994) Increase in plasma 3,4-dihydroxyphenylalanine (DOPA) appearance rate after inhibition of DOPA decarboxylase in humans. Eur J Clin Invest 24:205-211
11. El Mestikawy S, Hamon M (1986) Is dopamine-induced inhibition of adenylate cyclase involved in the autoreceptor-mediated negative control of tyrosine hydroxylase in striatal dopaminergic terminals? J Neurochem 47:1425-1433
12. Gjedde AH (1981) High- and low-affinity transport of D-glucose from blood to brain. J Neurochem 36:1463-1471
13. Gjedde AH (1982) Calculation of glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination. Brain Res Rev 4:237-274
14. Gjedde A, Léger G, Cumming P, Yasuhara Y, Evans AC, Guttman M, Kuwabara H (1993) Striatal L-DOPA decarboxylase activity in Parkinson's disease in vivo: implication for the regulation of dopamine synthesis. J Neurochem 61:1538-1541
15. Gjedde A, Reith J, Léger G, Cumming P, Yasuhara Y, Guttman M, Kuwabara H (1995) Brain-blood barrier removal of DOPA: role in regulation of dopamine synthesis and treatment of Parkinson's disease. In: New Concepts of a Blood-Brain Barrier (Greenwood J et al., eds), New York, Plenum Press, pp 103-109
16. Goldstein M, Bronaugh RL, Ebstein B, Roberge C (1976) Stimulation of tyrosine hydroxylase activity by cyclic AMP in synaptosomes and in soluble striatal enzyme preparations. Brain Res 109:563-574
17. Hadjiconstantinou M, Wemlinger TA, Sylvia CP, Hubble JP, Neff NH (1993) Aromatic L-amino acid decarboxylase of mouse striatum is modulated via dopamine receptors. J Neurochem 60:2175-2180
18. Hashiguti H, Nakahara D, Maruyama W, Naoi M, Ikeda T (1993) Simultaneous determination of in vivo hydroxylation of tyrosine and tryptophan in rat striatum by microdialysis-HPLC: relationship between dopamine and serotonin biosynthesis. J Neural Transm 93:213-223
19. Levine RA, Kuhn DM, Lovenberg W (1979) The regional distribution of hydroxylase co-factor in rat brain. J Neurochem 32:1575-1578
20. Melamed E, Hefti F, Wurtman RJ (1980) Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions. Proc Natl Acad Sci USA 77:4305-4309
21. Nakamura S, Goshima Y, Yue JL, Misu Y (1992) Transmitter-like basal and K+-evoked release of 3,4-dihdroxyphenylalanine from the striatum in conscious rats studied by microdialysis. J Neurochem 58:270-275
22. Nisenbaum LK, Abercrombie ED, (1992) Enhanced tyrosine hydroxylation in hippocampus of chronically stressed rats upon exposure to a novel stressor. J Neurochem 58:276-281
23. Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3:1-7
24. Potkin SG, Cannon-Spoor HE, DeLisi LE, Neckers LM, Wyatt RJ (1983) Plasma phenylalanine tyrosine and tryptophan in schizophrenia. Arch Gen Psychiatry 40:749-752
25. Pradhan S, Alphs L, Lovenberg W. (1981) Characterization of haloperidol-mediated effects on rat striatal tyrosine hydroxylase. Neuropharmacologv 20:149-154
26. 18F]fluoro-L-DOPA in rat. J Cereb Blood Flow Metab 10:707-719
27. Strait KA, Kuczenski R (1986) Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase. Mol Pharmacol 29:561-569
28. Tam SY, Roth RH (1997) Mesoprefrontal dopaminergic neurons: can tyrosine availability influence their functions? [Review, 60 refs] Biochem Pharmacol 53:441-453
29. Tammela O, Pastuszko A, Lajevardi NS, Delivoria-Papdopoulos M, Wilson DFO (1993) Activity of tyrosine hydroxylase in striatum of newborn piglets in response to hypocapnic hypoxia. J Neurochem 60:1399-1406
30. Thiede HM, Kehr W (1981) Endogenous DOPA in brain. Occurrence, distribution and relationship to changes in catecholamine synthesis. Naunyn Schmiedebergs Arch Pharmacol 316:299-303
31. Westerink BHC, van Es TP, Spaan SJ (1982) Effects of drugs interfering with dopamine and noradrenaline biosynthesis on the endogenous 3,4-dihydroxyphenylalanine levels in rat brain. J Neurochem 39:44-51
32. Westerink BHC, De Vries JB, Duran R (1990) Use of microdialysis for monitoring tyrosine hydroxylase activity in the brain of conscious rats. J Neurochem 54:381-387
33. Woods SK, Meyer JS (1991) Exogenous tyrosine potentiates the methylphenidate-induced increase in extracellular dopamine inthe nucleus accumbens: a microdialysis study. Brain Res 560:97-105
34. Zigmond MJ, Wurtman RJ (1970) Daily rhythm in the accumulation of brain catecholamines synthesized from circulating H3-tyrosine. J Pharmacol Exp Ther 172:416-422
35. Zivkovic B, Guidotti A, Costa E (1974) Effects of neuroleptics on striatal tyrosine hydroxylase: changes in affinity for the pteridine cofactor. Mol Pharmacol 10:727-735
36. Zhu MY, Juorio AV, Paterson IA, Boulton AA (1992) Regulation of the aromatic L-amino acid decarboxylase by dopamine receptors in rat brain. J Neurochem 58:636-641